InsiderTrades

Form 4 for ISPC iSpecimen Inc.

Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001104659-22-026697 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-02-24 2022-02-22+ ISPC Ianelli Christopher Pres, CEO, Dir M - OptEx $1.00 +51.2K 398.5K +15% +$51.2K
DM 2022-02-24 2022-02-22+ ISPC Ianelli Christopher Pres, CEO, Dir M - OptEx $0.00 -51.2K 49.5K -51% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-23 M A 48,106 $1.00 446,646 D — — (F2) Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options.
2 Common Common Stock 2022-02-22 M A 3,099 $1.00 398,540 D — — (F2) Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options.
3 Derivative Option 2022-02-23 M D 48,106 $0.00 1,409 D $1.00 · — to 2029-07-12 48,106 Common Stock (F5) Represents remaining granted stock options across all grants. (F4) Represents the stock options granted to the Reporting Person on July 13, 2019, pursuant to the Issuer's 2010 Stock Incentive Plan, which were fully vested on July 14, 2019.
4 Derivative Option 2022-02-22 M D 3,099 $0.00 49,515 D $1.00 · — to 2029-01-31 3,099 Common Stock (F5) Represents remaining granted stock options across all grants. (F3) Represents a portion of the stock options granted to the Reporting Person on April 26, 2019, pursuant to the Issuer's 2013 Stock Incentive Plan, which were fully vested on November 30, 2021.